Mastek Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Published 3 Aug 2026 | IT - Software | Market Cap: ₹5.7K Cr

Mastek expects significant overall services growth driven by AI investments. - Short-term uncertainties and decision-making delays exist, but strong optimism about AI-led technology disruption remains. - North America is projected to see growth, especially in healthcare and life sciences, with improving order book to revenue conversion. - U.K. Mastek anticipates steady and positive growth in H2 FY26 despite macro and global uncertainties (Page 14).

From Mastek Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Price

₹1,705

Market Cap

₹5.7K Cr

P/E Ratio

12.9

How does Mastek Ltd rank in IT - Software?

Compare Mastek Ltd against every IT - Software company this quarter on revenue, margins and earnings-call signals.

View IT - Software leaderboard →

Mastek Ltd — Quarterly revenue & net profit

Revenue Net Profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹938 Cr, net profit ₹106 Cr.

Full financials →

📊 Revenue & Sales Performance

→Mastek expects significant overall services growth driven by AI investments.
→Short-term uncertainties and decision-making delays exist, but strong optimism about AI-led technology disruption remains.
→North America is projected to see growth, especially in healthcare and life sciences, with improving order book to revenue conversion.
→U.K. maintains a strong position with sizable multi-year renewals in secured government services and private sector growth.
→AMEA region focused on profitable growth, especially in healthcare with multi-million-dollar AI-led transformation deals.
→AI for technology drives efficiency gains allowing higher revenue per resource; AI for business expected to fuel large future transformations starting FY '27.
→Operational efficiencies and AI-led delivery improvements are expected to enhance margins and bottom-line performance.
→Overall, a positive outlook with expectations of good growth in H2 2025 and beyond.

📈 Profitability & Margins

→Mastek anticipates steady and positive growth in H2 FY26 despite macro and global uncertainties (Page 14).
→Operational EBITDA improved 6% QoQ and 1.7% YoY in Q2, with margins increasing by 50 bps, indicating margin expansion potential (Page 2).
→Revenue per resource is expected to rise due to AI-driven efficiency gains, supporting margin improvement (Page 13).
→North America segment is poised for growth; approaching a $28-30 million run rate may lead to double-digit EBIT margins (Page 12).
→Company is focused on AI-led business transformation opportunities to drive disproportionate growth (Page 14).
→Shorter-term contracts in North America could lead to improved order book to revenue conversion ratios, supporting revenue growth (Page 12).
→Prudent reinvestment of efficiency gains into AI and business innovations might moderate short-term margins but support long-term profitability (Page 13).

See what Mastek Ltd said on profitability & margins — free account, 30 seconds.

🏗️ Capital Expenditure Plans

→Mastek is heavily investing in AI, focusing on both AI-for-technology (improving productivity and efficiency in technology services) and AI-for-business (delivering AI-led business transformation solutions).
→The company is investing in building solutions, assets, and proof of concepts in AI, with about a dozen engagements underway to build AI-for-business roadmaps for mid-market customers.
→Investments include hiring new leadership and strengthening capabilities, especially in North America, to drive growth in healthcare and life sciences.
→The firm is making targeted investments in healthcare verticals, especially in the APAC and Middle East regions.
→While pursuing efficiency gains that partly flow back to customers, Mastek is also reinvesting some of these savings into growth areas such as AI transformation.
→Operational efficiency improvements across delivery and G&A functions are ongoing but not currently quantified.

💰 Fundraising & Capital Structure

→There is no mention of any current or planned new fundraising through debt or equity in the provided transcript.
→The company’s focus is on operational efficiency, AI-driven growth, and executing business strategies rather than raising new capital.
→A candidate for the Chief Financial Officer position is expected to join early next month, which may strengthen financial management going forward.
→The management emphasizes strong bottom-line performance and investment in growth areas like AI, but does not indicate plans for external financing at this time.

See what Mastek Ltd said on fundraising & capital structure — free account, 30 seconds.

📋 Order Book & Pipeline

→Mastek's 12-month order backlog as of Q2 FY'26 stood at approximately $280 million, reflecting a 2.2% sequential growth and a 6.8% year-on-year growth.
→Order book mix for the quarter is disproportionately high from the U.K./Europe business, which involves significant long-term contracts.
→In North America, shorter-term contracts are more common recently, with clients preferring 6-month to 1-year deals instead of 3- to 5-year deals, causing order book growth to be muted but possibly improving revenue conversion ratios.
→The overall order book growth rate has slowed down to about 7% year-on-year, partly due to delayed decision-making and clients evaluating AI impacts on budgets.
→No regional bifurcation of order book is disclosed routinely; instead, regional performance and outlook are shared.
→One-off deal revenue of around $0.5 million is expected to be recognized in future quarters.

Key Metrics

What Mastek's management said in earlier quarters

Others in IT - Software this season

Quick Heal Technologies Ltd (Q2 FY26)
International revenue currently constitutes about 20% of Enterprise revenue. Key concall takeaways from Quick Heal Technologies Ltd's Q2 FY26 earnings call…
Sonata Software Ltd (Q2 FY26)
Increasing AI integration and modernization engineering focus to drive growth, with AI order book growing from 8% to 10%. Key concall takeaways from Sonata…
S A Tech Soft. (Q2 FY26)
Profitability: H1 FY26 saw lower profitability due to 13% rise in employee costs (sales, marketing, AI investment). Key concall takeaways from S A Tech…
CapitalNumbers (Q2 FY26)
Strategic acquisitions planned, with INR40 crores earmarked for M&A focused on companies in Salesforce, AI, Cloud, or digital engineering domains to expand…

Compare:vs TCS vs Infosys vs HCL Technologies Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Mastek Ltd Q2 FY26 results?

What is Mastek Ltd share price analysis?

Mastek Ltd currently shows a neutral. The stock trades at a P/E of 12.9 with a market cap of ₹5,667 Cr. Investors should review the full earnings analysis for detailed insights.

Is Mastek Ltd planning capital expenditure?

Mastek is heavily investing in AI, focusing on both AI-for-technology (improving productivity and efficiency in technology services) and AI-for-business (delivering AI-led business transformation solutions).

Keep Mastek Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.